Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.22

€4.22

1.430%
0.06
1.430%
€7.00
 
14.01.26 / Tradegate WKN: A3MQR6 / Name: Viromed Medical / Stock / ? / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Viromed Medical

sharewise wants to provide you with the best news and tools for Viromed Medical, so we directly link to the best financial data sources.

News

Viromed Medical AG: MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026
Viromed Medical AG: MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026


On 12 February 2026, Hannover Medical School (MHH) – represented by Prof. Dr. Hortense Slevogt – plans to hold a press conference together with the team from the Helmholtz Centre for Infection

EQS-News: Viromed Medical AG switches to registered shares
EQS-News: Viromed Medical AG switches to registered shares
EQS-News: Viromed Medical AG switches to registered shares
EQS-News: Viromed AG: Strategic Update on Operational Focus and Value Creation
EQS-News: Viromed AG: Strategic Update on Operational Focus and Value Creation
EQS-News: Viromed AG: Strategic Update on Operational Focus and Value Creation
EQS-Adhoc: Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
EQS-Adhoc: Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
EQS-Adhoc: Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
EQS-Adhoc: Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
EQS-Adhoc: Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
EQS-Adhoc: Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
EQS-News: Viromed Medical AG: Reallocation of Viromed shares broadens investor base
EQS-News: Viromed Medical AG: Reallocation of Viromed shares broadens investor base
EQS-News: Viromed Medical AG: Reallocation of Viromed shares broadens investor base